The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Metabolomics in Toxicology: Preclinical and Clinical Applications
Open accessAbstract
Metabolomics first burst into the toxicology arena approximately 10–12 years ago, experiencing rapid growth as a science in the intervening period (Fig. 1). Though metabolomics still trails the publication rates of its sister technologies, genomics and proteomics, it is closing the gap in terms of both the numbers of publications and the quality of those publications. One continuing source of confusion is differentiating the terms metabolomics, metabonomics, and metabolic profiling. Although metabonomics was the first term formally defined (Nicholson et al., 1999), the term metabolomics came into usage shortly thereafter (Fiehn, 2002). Metabolic profiling is used by some as a generic term to avoid confusion of the two aforementioned ‘‘omic’’ terms, but that phrase itself can be confused with the comprehensive metabolite analysis of xenobiotics, so it is debatable whether its use adds any clarity to the situation. Whatever the case, it is now clear that metabolomics is the term preferred by most practitioners (Fig. 1). Therefore, metabolomics will be used in this review with the understanding that it represents all three terms. For most people, the names can be used interchangeably, but the reader is still advised to utilize all three terms when performing literature searches. Now that we have determined what to call it, we need to define what it is. The literature is replete with fine-tuned definitions, but the most succinct definition still appears to be most appropriate, and that is that metabolomics is ‘‘the comprehensive and quantitative analysis of all metabolites’’ (Fiehn, 2001). Every word in that phrase could be subject to debate as no analytical technique can measure ‘‘all’’ metabolites and what exactly qualifies as a metabolite? Do dietaryderived metabolites qualify, what about gut flora–derived metabolites? Rather than wade into this academic argument, we will leave it to the reader to define metabolomics as he or she chooses. For the toxicologist, the important point is that a metabolomics approach has the potential to reveal novel biochemical sequelae of toxicant administration that can lead to mechanistic insights and identification of biomarkers of cause and/or effect. Furthermore, the technology has the potential to characterize models or disease states to provide biochemical bases for observed interactions with xenobiotics. Given the explosion of recent literature, this review will not revisit the origins of metabolomics to any extent but will focus on recent advances in the field. Although botanical, environmental, and nutritional applications of the technology have expanded with the field, there is now such a wealth of literature this review will not be able to cover those burgeoning areas of metabolomic research. After providing some historical perspective, this review focuses on the biomedical applications of metabolomic technology with emphasis on new analytical approaches, preclinical, and clinical applications of the technology, particularly those areas relevant to practicing toxicologists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sumner, L. W., Amberg, A., Barrett, D., Beale, M. H., Beger, R., Daykin, C. A., Fan, T. W.-M., Fiehn, O., Goodacre, R., Griffin, J. L., et al. (2007) · Metabolomics · doi:10.1007/s11306-007-0082-2 · Cited by 5,368
Self-citationMetabolomics—the link between genotypes and phenotypes
Fiehn, O. (2002) · Plant Molecular Biology · doi:10.1023/a:1013713905833 · Cited by 3,445
Newgard, C. B., An, J., Bain, J. R., Muehlbauer, M. J., Stevens, R. D., Lien, L. F., Haqq, A. M., Shah, S. H., Arlotto, M., Slentz, C. A., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.02.002 · Cited by 3,165
Human metabolic phenotype diversity and its association with diet and blood pressure
Holmes, E., Loo, R. L., Stamler, J., Bictash, M., Yap, I. K. S., Chan, Q., Ebbels, T., De Iorio, M., Brown, I. J., Veselkov, K. A., et al. (2008) · Nature · doi:10.1038/nature06882 · Cited by 1,054
Dumas, M.-E., Barton, R. H., Toye, A., Cloarec, O., Blancher, C., Rothwell, A., Fearnside, J., Tatoud, R., Blanc, V., Lindon, J. C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601056103 · Cited by 1,042 · cited 2×
“The above examples highlight that a key area of metabolomic research over the past 10 years has been with regard to the role gut microflora plays with systemic biochemistry (Calvani et al., 2010; Dumas et al., 2006; Fava et al., 2006; Martin et al., 2007; Nicholson, 2008; Nicholson and Wilson, 2003; Nicholson et al.,…”
BackgroundGut microorganisms, mammalian metabolism and personalized health care
Nicholson, J. K., Holmes, E., & Wilson, I. D. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1152 · Cited by 945
Pharmaco-metabonomic phenotyping and personalized drug treatment
Andrew Clayton, T., Lindon, J. C., Cloarec, O., Antti, H., Charuel, C., Hanton, G., Provost, J.-P., Le Net, J.-L., Baker, D., Walley, R. J., et al. (2006) · Nature · doi:10.1038/nature04648 · Cited by 824
Data processing for mass spectrometry-based metabolomics
Katajamaa, M., & Orešič, M. (2007) · Journal of Chromatography A · doi:10.1016/j.chroma.2007.04.021 · Cited by 616
Scalbert, A., Brennan, L., Fiehn, O., Hankemeier, T., Kristal, B. S., van Ommen, B., Pujos-Guillot, E., Verheij, E., Wishart, D., & Wopereis, S. (2009) · Metabolomics · doi:10.1007/s11306-009-0168-0 · Cited by 565
An, J., Muoio, D. M., Shiota, M., Fujimoto, Y., Cline, G. W., Shulman, G. I., Koves, T. R., Stevens, R., Millington, D., & Newgard, C. B. (2004) · Nature Medicine · doi:10.1038/nm995 · Cited by 450
Martin, F. J., Wang, Y., Sprenger, N., Yap, I. K. S., Lundstedt, T., Lek, P., Rezzi, S., Ramadan, Z., van Bladeren, P., Fay, L. B., et al. (2008) · Molecular Systems Biology · doi:10.1038/msb4100190 · Cited by 421
Susceptibility of Human Metabolic Phenotypes to Dietary Modulation
Stella, C., Beckwith-Hall, B., Cloarec, O., Holmes, E., Lindon, J. C., Powell, J., van der Ouderaa, F., Bingham, S., Cross, A. J., & Nicholson, J. K. (2006) · Journal of Proteome Research · doi:10.1021/pr060265y · Cited by 376
Gut microbiome-derived metabolites characterize a peculiar obese urinary metabotype
Calvani, R., Miccheli, A., Capuani, G., Tomassini Miccheli, A., Puccetti, C., Delfini, M., Iaconelli, A., Nanni, G., & Mingrone, G. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.44 · Cited by 241
Metabolite profiling of fecal water extracts from human colorectal cancer
Monleón, D., Morales, J. M., Barrasa, A., López, J. A., Vázquez, C., & Celda, B. (2009) · NMR in Biomedicine · doi:10.1002/nbm.1345 · Cited by 186
Atherton, H. J., Bailey, N. J., Zhang, W., Taylor, J., Major, H., Shockcor, J., Clarke, K., & Griffin, J. L. (2006) · Physiological Genomics · doi:10.1152/physiolgenomics.00060.2006 · Cited by 159
The human gut microbiome: Implications for future health care
Kinross, J. M., von Roon, A. C., Holmes, E., Darzi, A., & Nicholson, J. K. (2008) · Current Gastroenterology Reports · doi:10.1007/s11894-008-0075-y · Cited by 137
Makowski, L., Noland, R. C., Koves, T. R., Xing, W., Ilkayeva, O. R., Muehlbauer, M. J., Stevens, R. D., & Muoio, D. M. (2009) · The FASEB Journal · doi:10.1096/fj.08-119420 · Cited by 113
Backshall, A., Alferez, D., Teichert, F., Wilson, I. D., Wilkinson, R. W., Goodlad, R. A., & Keun, H. C. (2009) · Journal of Proteome Research · doi:10.1021/pr800793w · Cited by 42
Cited by
Microfluidics for single cell analysis
Yin, H., & Marshall, D. (2012) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.11.002 · Cited by 394
Lankadurai, B. P., Nagato, E. G., & Simpson, M. J. (2013) · Environmental Reviews · doi:10.1139/er-2013-0011 · Cited by 385
Overview of Mass Spectrometry-Based Metabolomics: Opportunities and Challenges
Gowda, G. A. N., & Djukovic, D. (2014) · Methods in Molecular Biology · doi:10.1007/978-1-4939-1258-2_1 · Cited by 334
Pathogenesis of Idiosyncratic Drug-Induced Liver Injury and Clinical Perspectives
Fontana, R. J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.12.032 · Cited by 313
MEDICAL DEVICES EARLY ASSESSMENT METHODS: SYSTEMATIC LITERATURE REVIEW
Markiewicz, K., van Til, J. A., & IJzerman, M. J. (2014) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462314000026 · Cited by 87
Metadata
- Authors
- Robertson, D. G., Watkins, P. B., & Reily, M. D.
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-12-02
- Volume
- 120
- Issue
- Supplement 1
- Pages
- S146-S170
- ISSN
- 1096-0929 (ISSN-L)
- 1096-6080
- OpenAlex
- W2150681237
- Cited by
- 211
- References
- 18
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.